Medicilon’s CEO
Visiting Professor of China Pharmaceutical University
CEO Message
Chunlin Chen, Ph.D. CEO
Dear Friends,
Through our efforts, Medicilon has grown into one of the top drug discovery service companies in China. We have developed our wholly integrated capabilities across chemistry, biology and preclinical services. We now have the largest AAALAC-certified animal research facility in Shanghai complementing 3 technology platforms, including structural biology, non-human primate experimental lab, and isotope lab. We strive to improve our services to satisfy our global clients’ needs, and now, we are pleased to announce that we operate in both US GLP and CFDA GLP certified standards.
Medicilon has provided services and collaborated with over 150 companies around the world. We pledge to serve our clients with the highest level of quality, efficiency, passion and commitment. We believe that the ultimate goal of a successful drug-to-market endeavor corresponds with our clients’ unrivaled satisfaction in every project. We are proud of the work we do with our clients as we continuously strive to make progressive impacts in drug discovery so that our work today can ensure a healthier world tomorrow.
Thank you and we are looking forward to working with you.
Chunlin Chen, Ph.D.
CEO
Shanghai Medicilon Inc.